Volume 5 Supplement F December 2009

Vascular Restoration Therapy: the fourth revolution in interventional cardiology and the ultimate “Rosy” prophecy

• Wykrzykowska J,
• Onuma Y,
• Serruys PW

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F7-F8

Bioabsorbable polymers in medicine: an overview

• Vert M

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F9-F14

Design principles and performance of bioresorbable polymeric vascular scaffolds

• Oberhauser J,
• Hossainy S,
• Rapoza R

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F15-F22

ABC’s of bioabsorption: application of lactide based polymers in fully resorbable cardiovascular stents

• van Alst M,
• Eenink M,
• Kruft M,
• van Tuil R

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F23-F27

The bioabsorption process: tissue and cellular mechanisms and outcomes

• Vorpahl M,
• Finn A,
• Nakano M,
• Virmani R

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F28-F35

Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent

• Waksman R,
• Pakala R

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F36-F42

Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?

• Bangalore S,
• Mauri L

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F43-F48

Vascular restoration therapy: what should the clinical and angiographic measures for success be?

• Khattab A,
• Windecker S

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F49-F53

Engineering a bioresorbable stent: REVA programme update

• Pollman M

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F54-F57

Novel fully bioabsorbable salicylate-based sirolimuseluting stent

• Jabara R,
• Pendyala L,
• Geva S,
• Chen J,
• Chronos N,
• Robinson K

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F58-F64

OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings

• Cottone R,
• Thatcher L,
• Parker S,
• Hanks L,
• Kujawa D,
• Rowland S,
• Costa M,
• Schwartz R,
• Onuma Y

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F65-F71

Challenges related to development of bioabsorbable vascular stents

• Berglund J,
• Guo Y,
• Wilcox J

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F72-F79

Elixir Medical\'s bioresorbable drug eluting stent (BDES) programme: an overview

• Yan J,
• Bhat V

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F80-F82

A.R.T.: concept of a bioresorbable stent without drug elution

• Lafont A,
• Durand E

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F83-F87

NEVO™: a new generation of sirolimus-eluting coronary stent

• Falotico R,
• Parker T,
• Grishaber R,
• Price S,
• Cohen S,
• Rogers C

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F88-F93

Current state of the absorbable metallic (magnesium) stent

• Waksman R

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F94-F97

Everolimus-eluting bioabsorbable stent – Abbot Vascular programme

• Onuma Y,
• Piazza N,
• Ormiston J,
• Serruys PW

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F98-F102

Assimilating the current clinical data of fully bioabsorbable stents

• Di Mario C,
• Borgia F

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F103-F108

Ten-year follow-up of the IGAKI-TAMAI stent.

• Onuma Y,
• Garg S,
• Okamura T,
• Ligthart J,
• van Geuns R-J,
• de Feyter P,
• Serruys PW,
• Tamai H

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F109-F111